CBER Reorganization Poses “Significant” Staff Retention Issues – Zoon
This article was originally published in The Gray Sheet
Executive Summary
The reorganization of FDA's Center for Biologics Evaluation & Research poses a significant problem for employee retention, Director Kathryn Zoon told the FDA Science Board Oct. 25